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Background: Herpes simplex virus (HSV) type 1 has a 152 kb double-stranded DNA genome that may encode more
than 80 gene products, many of which remain uncharacterized. The HSV-1 triplex is a complex of three protein subunits,
VP19C and a dimer of VP23 that is essential for capsid assembly. Previous studies have demonstrated that HSV-1 VP19C
contains an atypical nuclear localization signal and a functional nuclear export signal (NES), which are both important for
the nucleocytoplasmic shuttling of VP19C. However, whether the VP19C NES is required for efficient HSV-1 production
is unknown.
Findings: In the present study, a VP19C NES-mutated recombinant virus was generated by using bacterial artificial
chromosome recombineering technology to investigate the role of VP19C nuclear export in HSV-1 replication.
Our results demonstrate that the growth curves, plaque areas, subcellular localization and viral gene expression
are indistinguishable between the VP19C NES-mutated virus and the wild-type virus.
Conclusions: Our findings reported herein indicate abrogation of the nuclear export of VP19C did not affect
HSV-1 replication and viral gene expression.
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Construction of a VP19C NES-mutated BAC with
recombineering technology
VP19C is a capsid protein of Herpes simplex virus
(HSV) type 1, which is essential for the assembly of the
capsid shell structure. If VP19C is absent, the capsid
shells do not form. VP19C is reported to be essential for
efficient transport of VP23 and VP5 to the nucleus,
which is the site of capsid assembly [1]. A previous study
revealed a leucine-rich sequcnce “342LERLFGRLRI351” in
VP19C functioning as a nuclear export signal (NES) was
responsible for its nucleocytoplasmic shuttling [2]. Re-
placement of key residues in the NES with alanines
disrupts the shuttling of VP19C between the cyto-
plasm and nucleus. Cloning of the HSV-1 genome* Correspondence: zhaobine@126.com; likeshen1971@126.com
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has facilitated genetic manipulation of the HSV-1 genome
in Escherichia coli (E. coli). To investigate whether abroga-
tion of VP19C nuclear export has an effect on HSV-1 lytic
replication, a VP19C NES-mutated recombinant virus
was constructed. Recombinant HSV-1 harboring the
VP19C NES mutation was generated by a two-step
Red-mediated recombination system in E. coli GS1783
strain using a HSV-1 17-37BAC [3]. The scheme of
constructing a VP19C NES-mutated BAC was shown in
Figure 1. Primer sequences used for BAC mutagenesis are
listed in Table 1. Construction of the recombinant BAC
pVP19C NESm/17-37BAC was performed as described
previously [4]. The clones with the desired recombination
were selected on kanamycin- and L-arabinose-containing
plates and then subjected to PCR and restricted fragment
length polymorphisms (RFLP) analysis. The mutant
pVP19C NESm/17-37BAC showed BamHI digestion
patterns similar to that of wild-type 17–37 BAC, while
the pVP19C NESm/Kan/17-37BAC presented band vari-
ations approximately 6–8 kb fragments due to the inser-
tion of a KanR cassette (Figure 2A). The restrictionhis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Figure 1 Generation of VP19C NES mutants by mutagenesis. (A) Schematic representation of the HSV-1 genome containing terminal long
(TRL) and short (TRS) and internal long (IRL) and short (IRS) repeats flanking the unique long (UL) and short (US) regions. (B) The NES mutations
were introduced by using two-step red recombination. The sequences corresponding to the first (red and wathet) and second (blue) recombination
events are shown in the indicated colors. (C) PCR products containing ~40 bp of homologous sequences upstream (red) and downstream (wathet) of
the target loci, ~40 bp of complementary sequences (blue) encoding the mutations and I-SceI site, or the KanR gene were electroporated into competent
GS1783 E. coli containing the HSV-1 17-37BAC. After the first recombination, the PCR product was inserted into the homologous location within the
UL38 gene. After confirming that the PCR product was inserted into the correct locus by using RFLP and Southern blot hybridizations, the
second recombination was performed in which the KanR gene plus one of the complimentary homologous sequences were removed. The
remaining genome contained the complete VP19C ORF with the corresponding mutations.
Table 1 Primers used for generation of recombinant VP19C-NESm/17-37BAC
Primers Directiona Sequenceb
VP19C NESm forward CCGGCCGCAGAGCGGGCATTTGGGCGCGCACGGGCAACCAACACGATTCACGGCAC
reverse GTTGGTTGCCCGTGCGCGCCCAAATGCCCGCTCTGCGGCCGGCTCCAACCCG




BAC sequencing reverse TAACAACGGGGACGCTGACCG
aDirectionality of the primer.
bNucleotides in boldface type indicate priming sites within mutagenesis template plasmid pEP-KanS for amplification of KanR cassette.
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no gross mutation was detected and the mutations oc-
curred at the expected loci.
Abrogation of VP19C nuclear export did not affect
HSV-1 replication
To investigate the effect of the NES mutation of VP19C
on the life cycle of HSV-1, 1–2 μg of recombinant
pVP19C NESm/17-37BAC DNA was electroporated into
Vero cells to reconstitute the VP19C NESm/17-37BAC
virus (Figure 2B). Sequence analysis confirmed that the
NES mutation in VP19C was not repaired during viral
replication (Figure 2C), which indicated that the NES is
not required for virus growth in vitro.
To compare the in vitro growth properties of VP19C
NESm/17-37BAC virus with those of the parental virus
and wild-type HSV-1, single step growth kinetics were
determined as described previously [4]. As shown in
Figure 2D, the VP19C NESm/17-37BAC virus showed
growth kinetics almost identical to that of the parental
17-37BAC virus and wild-type HSV-1 on Vero cells
(Figure 2D). Plaque diameters were measured following
infection of Vero cells with VP19C NESm/17-37BAC,
17-37BAC or wild-type HSV-1 viruses in 6-well plates.
There were no significant differences observed between
the plaque diameters of the recombinant virus, the par-
ental virus and the wild-type virus (Figure 2E).
Abrogation of VP19C nuclear export did not affect
subcellular localization of VP19C and viral gene
expression
Immunofluorescence staining was applied to visualize
the subcellular localization of VP19C in wild-type HSV-1
and VP19C NESm/17-37BAC virus-infected cells. As
shown in Figure 2F, VP19C displayed a nuclear localization
in VP19C NESm/17-37BAC virus-infected cells as it did in
wild-type HSV-1-infected cells, indicating that the NES
mutation of VP19C did not affect its nuclear localization in
infection background.
Western blot was also performed to detect the expres-
sion of virion proteins VP19C, VP23 and VP22. As it is
shown in Figure 2G and H, the expression of VP19C,
VP23 and VP22 was unchanged. These results collect-
ively indicated that abrogation of VP19C nuclear export
does not affect subcellular localization of VP19C and
viral gene expression.
Discussion
The HSV-1 capsid is the most morphologically regular
component of the virus structure. VP19C is an integral
capsid protein that interacts with VP23 to form the trip-
lex, which is the unit that forms the capsid. Capsid as-
sembly of HSV-1 is known to take place in the nuclei of
infected cells. It is reported that correct transport of theprotein components to the site of capsid assembly is an
important function of VP19C [5]. Because of its nuclear
localization signal (NLS) and NES, VP19C is able to
shuttle between the nucleus and the cytoplasm as
part of a chromosome region maintenance 1 (CRM1)
dependent pathway as well as through the atypical
Ran- and importin β-dependent, but not importin α5,
mechanisms [4]. These lines of evidence suggest that
VP19C and VP23 may interact in the cytoplasm, and
then, VP23 is translocated into the nucleus because of the
NLS on VP19C to participate in capsid assembly.
The hydrophobic residues in the NES are important for
nuclear export of VP19C, and VP19C is exported from the
nucleus through the NES via a CRM1-dependent pathway.
However, CRM1-mediated transport is highly subjected
to various regulation processes, including the masking of
NES, phosphorylation and heterodimerization of the pro-
tein and formation of disulfide bonds by an oxidative
process [6]. Phosphorylation of residues in the vicinity of
the NES and NLS may regulate the intracellular distribu-
tion of a protein [6]. For example, several viral proteins,
such as the Rabies virus P-protein and chicken anemia
virus VP3, regulate their NLS/NES activity via phosphor-
ylation [6]. Additionally, the availability of specific cofac-
tors may also influence this regulation. The mechanism by
which subcellular localization is regulated and whether it
is regulated over the course of HSV-1 infection will be
interesting to determine.
BAC recombineering allows for the rapid and efficient
modification of viral genomes in E. coli, thus providing
an invaluable tool for the genetic manipulation of her-
pesvirus genomes and the production of altered forms of
viruses to decipher the specific function of a gene in the
virus life cycle and pathogenesis [7]. In the present
study, we constructed a VP19C NES-mutated recombin-
ant virus using BAC recombineering technology. The
recombinant virus with the NES mutation in VP19C did
not impair virus replication, and viral gene expression
was also unaffected. Our previous study identified a
non-classical NLS of VP19C, and the nuclear import of
VP19C is required for efficient HSV-1 production [4].
These lines of evidence together suggest that the role of
nuclear import and export may function differently in
HSV-1 lytic replication. HSV-1 ICP27 was shown to
shuttle between the nucleus and cytoplasm through a
leucine-rich NES in a CRM1-dependent pathway [8].
However, ICP27 shuttling is not involved in viral DNA
replication, but affects the expression of HSV-1 late
genes [9]. Li et al. also identified a functional NLS and
NES in ORF45 of Kaposi’s sarcoma-associated herpes-
virus 8, and demonstrated that the NES is important for
ORF45 nucleocytoplasmic shuttling. However, only the
NLS-mutated virus had impaired virus production, and
the NES-mutated virus did not affect viral replication
Figure 2 Identification of the role of VP19C NES in HSV-1 life cycle. (A) RFLP analysis of BAC recombinant variants. Parental p17-37BAC,
pVP19C NESm/Kan/17-37BAC and pVP19C NESm/17-37BAC were digested with BamHI. The sizes of the molecular markers are shown on the left.
(B) VP19C NESm/17-37BAC recombinant virus reconstitution. pVP19C NESm/17-37BAC DNA electroporated into Vero cells caused cytopathic
effects (CPE) (middle panel) with green fluorescence (right panel), while no CPE were observed in mock-transfected Vero cells (left panel). (C) The
sequence of the VP19C NESm recombinant virus at the VP19C loci is shown. (D) The growth properties of wild-type HSV-1, parental 17-37BAC
and VP19C NESm/17-37BAC were compared. Vero cells were infected with wild-type HSV-1, parental 17-37BAC or VP19C NESm/17-37BAC virus at
an MOI of 1, and virus was harvested at the indicated time points and titrated on a Vero monolayer. The data plotted show the mean of three
independent experiments. (E) Individual plaque area assays of wild-type, parental and recombinant VP19C NESm/17-37BAC virus are shown. The
diameter of 80 plaques was measured for each virus, and the means ± standard deviations of the diameters were calculated and are shown.
(F) Immunofluorescence assay for detecting the subcellular localization of VP19C in wild-type HSV-1 and VP19C NESm/17-37BAC virus-infected
cells. Vero cells were infected with wild-type HSV-1 or VP19C NESm/17-37BAC virus at an MOI of 3 for 12 h and then probed with antibody
against VP19C. (G) Western blot analysis of virion lysates was performed. Vero cells were infected with wild-type HSV-1, parental 17-37BAC or the
VP19C NESm/17-37BAC virus at an MOI of 3. Expression was determined in cell lysates by Western blot analysis with antibodies against VP19C,
VP22 and VP23. (H) The relative expression of virion proteins in the lysates was analyzed using Quantity One Imaging Software (Bio-Rad).
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other cellular proteins (such as nuclear pore complexs)
or viral proteins (such as UL25) [4], it cannot be ex-
cluded that VP19C may export from the nucleus
through other pathways in the context of infection. Al-
though the NES seems dispensable for HSV-1 lytic repli-
cation in the present study, it might be important for
certain ancillary functions that could facilitate its inter-
action with the host.
In conclusion, our study provides evidence that the
nuclear export of VP19C is not essential for HSV-1 rep-
lication and viral gene expression. The potential role of
nucleocytoplasmic shuttling of VP19C played in the
HSV-1 viral life-cycle still needs to be further elucidated.
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